Background and Purpose-Spontaneous echo contrast (SEC) is frequently detected in patients with atrial fibrillation (AF).
S pontaneous echo contrast (SEC) refers to smoke-like echoes that are visualized in echocardiography because of ultrasound backscattered from red blood cell aggregates.
1 SEC is frequently detected in patients with atrial fibrillation (AF), which is the most common cardiac source of embolism.
2,3 AF patients with coexisting SEC may have increased frequency of intracardiac thrombus and increased risk of stroke. 4 Stroke patients with AF and concomitant cardiac sources of embolism had more severe stroke. 5 In addition, coexisting SEC in patients with AF may also increase thrombotic burden, which can cause a more severe stroke. In this study, we investigated whether stroke severity and functional outcome differ according to the presence of coexisting SEC in stroke patients with nonvalvular AF (NVAF).
Methods
This is a retrospective observational study that used a prospective cohort of patients with acute ischemic stroke. We included consecutive stroke patients with NVAF who were admitted within 7 days after symptom onset between January 2008 and December 2014. Transesophageal echocardiography (TEE) was performed within 2 weeks after admission. TEE was considered in all the patients except in those with decreased consciousness, impending brain herniation, poor systemic conditions, inability to accept a transducer because of swallowing difficulty or tracheal intubation, or lacked informed consent. SEC was graded as mild, moderate, and severe. Stroke severity at admission was assessed by using the National Institute Health Stroke Scale (NIHSS). Poor functional outcome was defined as a modified Rankin scale (mRS) score of >2 at 3 months. Details of stroke evaluation, TEE procedure, the definition of risk factors, and statistical analyses seen in the online-only Data Supplement. This study was approved by the Institutional Review Board of the Yonsei University Health System.
Results
During the 7-year period, 4252 consecutive stroke patients were registered to the cohort. Among them, 966 had AF (22.7%), of whom 517 (53.5%) underwent TEE. After excluding 77 patients who had valvular heart disease or were treated using a left atrial appendage (LAA) occluding device, 440 patients with NVAF were finally included in this study. Patients who did not undergo TEE were older than those underwent TEE, and were more likely women, more frequently had congestive heart failure, previous stroke history, higher CHA 2 DS 2 -VASc (congestive heart failure, hypertension, age, diabetes mellitus, Figure) . This result was not influenced by the status of anticoagulation at admission ( Figure I in the onlineonly Data Supplement). Stroke severity and the proportion of patients with poor functional outcome increased as the grade of SEC increased (Figures II and III in the online-only Data Supplement). On multiple logistic regression, the presence of SEC was an independent factor of poor outcome (odds ratio, 2.09; 95% confidence interval, 1.24-3.53; Table) .
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Discussion
In this study, 44% of the patients with NVAF had SEC, and patients with SEC more frequently had left atrial/LAA thrombus. These findings support the previous knowledge that SEC is frequent in patients with NVAF and associated with increased incidence of LAA thrombus. In addition, this study newly showed that the presence and degree of SEC were associated with an initially more severe stroke and worse functional outcome at 3 months after stroke onset. 
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Several explanations are possible for the severe stroke and poor outcomes in stroke patients with NVAF and coexisting SEC. Increased thrombogenecity in patients with SEC could be associated with increased risk of multiple or larger thrombus formation. This might cause larger infarctions, which result in more severe stroke. In this study, poor functional outcome at 3 months in the patients with SEC was independent of initial stroke severity and reperfusion therapy. This suggests that the presence of SEC or the condition that led to the development of SEC might also have a negative effect during the course of stroke.
SEC represents red blood cell aggregates. Experimental studies showed that red blood cell-rich thrombi are resistant to fibrinolytic agents. 6 In fact, thrombi in patients with AF and concomitant SEC were suggested to be more resistant to fibrinolysis. 7 Thus, endogenous fibrinolysis might less effectively occur in SEC-associated thrombus. In addition, patients with SEC more frequently had left atrial/LAA thrombus, which is a high-risk factor of recurrent stroke. 4 In this study, the patients with SEC showed higher red blood cell distribution width. Red blood cell distribution width is a predictor of SEC. 8 Increased red blood cell distribution width was associated with the future risk of stroke and poor functional outcomes in patients with acute stroke. 9 These factors could affect negatively the progression and recurrence of stroke during follow-up, resulting in poor long-term functional outcome.
This study has limitations. First, 46.5% of the patients with NVAF did not undergo TEE. This resulted in selection bias and differences in demographic characteristics, including more severe stroke in the patients who did not undergo TEE than those underwent TEE. Second, in this study population, the frequency of anticoagulation before the stroke was low (16.1%). Oral anticoagulation may affect the presence of SEC. In addition, this study was conducted in a single center. Therefore, our results may not be applicable to a different NVAF cohort. Finally, the recurrence of stroke, which might affect long-term functional outcome, was not determined. Therefore, these limitations should be considered in the interpretation of our findings.
Conclusions
Although currently the presence of SEC is mostly considered in the context of stroke risk prediction, our data suggest that it also portends poor clinical outcome in patient with stroke.
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Evaluations
Patients were routinely evaluated using brain magnetic resonance imaging and cerebral angiographic studies. Cardiac evaluation included 12-lead electrocardiography, transesophageal echocardiography (TEE), multidetector heart CT, and continuous electrocardiography monitoring in a stroke unit or Holter monitoring.
TEE was performed with a 5-MHz multiplane transesophageal transducer connected to an ultrasonographic system (iE33; Philips Medical Systems, Andover, Massachusetts). The LAA was observed at 0, 45, 90, and 135 degrees to detect SEC or thrombus. SEC was defined as dynamic smoke-like echoes swirling slowly in the LA or LAA cavity despite adjustment of the gain setting. SEC was graded as mild, moderate, and severe by cardiologists at the time of initial interpretation of TEE.
Risk factors
Hypertension was diagnosed in patients with systolic blood pressures of ≥140 mmHg or diastolic blood pressures of ≥90 mmHg in repeated measurements during resting status, or a history of antihypertensive drug use for diagnosed hypertension. Diabetes mellitus was defined as a fasting plasma glucose of ≥7.0 mmol/L (126 mg/dL), a random plasma glucose level of ≥11.1 mmol/L (200 mg/dL), an A1C level of ≥6.5%, or current use of oral hypoglycemic agents or insulin. Dyslipidemia was defined as a low-density lipoprotein cholesterol level of ≥4.1 mmol/L (160 mg/dL), a total cholesterol level of ≥6.2 mmol/L (240 mg/dL), a high-density lipoprotein cholesterol level of <1.0 mmol/L (40 mg/dL), or current use of lipid-lowering agents after diagnosis of dyslipidemia. A current smoker was defined as a patient who smoked within 1 year before admission. Previous stroke was defined as any history of ischemic or hemorrhagic stroke. Vascular disease, which is an element of the CHA 2 DS 2 -VASc score, included prior myocardial infarction, peripheral artery disease, and aortic plaques as was used in the CHA 2 DS 2 -VASc score.
Statistical analyses Continuous variables were expressed as mean ± standard deviation (SD), median (interquartile range [IQR]), and categorical variables were expressed as number (percentage).
To analyze baseline characteristics according to the presence of SEC, the chi-square test, the Student t-test, Wilcoxon rank-sum test, and generalized regression test were used. As for the factors associated with initial stroke severity, it was dichotomized by the median value of initial NIHSS score of the study population. After univariate analysis (chi-square test and Student's t-test), multivariate logistic regression analysis was performed. To determine the factors associated with poor functional outcome, multiple logistic regression analyses were performed by using age, sex, reperfusion therapy, and P values of <0.1 as variables in the univariate analysis. To avoid multicollinearity, the CHA 2 DS 2 -VASc score and its components were analyzed separately in the multivariate analysis. All statistical analyses were two-tailed, and P values of <0.05 were considered significant. All statistical processes were performed by using R version 3.2.1. 
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